Clinical Trial Update: POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation

View source ↗

Summary

A registered clinical trial studying POLE gene mutation as a prognostic factor in endometrial cancer across early and advanced stages; recruitment is by invitat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Azienda Ulss 2 Marca Trevigiana | Conditions: Endometrial Neoplasms | Status: ENROLLING_BY_INVITATION